Skip to main content

HbA1c Measures Higher in South Asians Than White Europeans


July 27, 2012 — Three measures of blood sugar — glycated hemoglobin (HbA1c) levels, fasting plasma glucose (FPG), and 2-hour β-plasma glucose (2hrPG) — were higher on average in South Asians than white Europeans regardless of other factors associated with glycemic control, according to results from a new study published online June 14 and in the August print issue of Diabetes Care.
Samiul A. Mostafa, MBCHB, from the Department of Cardiovascular Sciences, University of Leicester, United Kingdom, and colleagues analyzed screening data from 6040 people aged 40 to 75 years between 2005 and 2009. The data included 1352 South Asians and 4688 white Europeans.
The analysis showed HbA1c glucose levels to be significantly associated with ethnicity, FPG, 2hrPG, and homeostasis model assessment of β-cell function (P = .001), age and sex (P = .01), and fasting insulin and potassium (P = .05). When these and other risk factors were adjusted for, South Asians had higher levels, compared with white Europeans, of HbA1c (6.22% and 6.02%, respectively; mean difference, 0.19%; 95% confidence interval [CI], 0.11 - 0.27; P < .001), FPG (5.15 and 5.30 mmol/L, respectively; mean difference, 0.15 mmol/L; 95% CI, 0.09 - 0.21; P < .001), and 2hrPG (5.82 and 6.57 mmol/L, respectively; mean difference, 0.75 mmol/L; 95% CI, 0.59 - 0.92; P < .001).
Earlier studies have shown higher HbA1c levels to be independent of factors associated with glycemic control among blacks (by from 0.2% to 0.4%), Hispanics (by from 0.1% to 0.3%), and Southeast Asians (by from 0.2% to 0.3%). The authors say this study is the first to demonstrate the effect in South Asians.
The authors note that international organizations recommend the use of ethnic-specific targets for South Asians for body mass index, waist size, and metabolic syndrome, but not for HbA1c levels. A smaller percentage of South Asians with diabetes hit glycemic targets compared with white Europeans.
"Because our study demonstrates independently higher HbA1c, FPG, and 2hrPG levels in South Asians, this result may be partially explained by factors related to glycemia," the authors conclude. "Future research should address the relationship between HbA1c and the onset of diabetes complications, including prevalent retinopathy, between South Asians and white Europeans in well-designed outcome studies to determine if ethnic-specific cut points are required for diabetes diagnosis in South Asians."
The study was funded by the United Kingdom (UK) National Health Service Department of Health. Dr. Mostafa and a coauthor have received fellowships from Novo Nordisk UK Research Foundation; 2 coauthors have received research funds and honoraria for speaking at meetings and serving on advisory boards for Astra Zeneca, Eli Lilly, sanofi aventis, Merck Sharp & Dohme, Novo Nordisk, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Pfizer, and/or Servier. Two of the researchers serve as members of the National Institute for Health and Clinical Excellence Public Health Guidance on Prevention of Type 2 Diabetes Among People With Prediabetes and are advisors to the UK Department of Health for the NHS Health Checks Programme. .The other authors have disclosed no relevant financial relationships.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...